N0874: Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]), Temozolomide, and Radiation Therapy in Patients with Newly Diagnosed Glioblastoma

Grant

Date/time Interval

  • April 11, 2012 - December 31, 2013
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4096.00
  • Sponsor Award Id

  • Contributor

  • Nabors M.D., Louis   Principal Investigator